Qingguang G. Liu

No.277 Yanta West Road
Xi'an, 710061, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 140 publications

Retraction: CtBP2 is an independent prognostic marker that promotes GLI1 induced epithelialmesenchymal transition in hepatocellular carcinoma.

Retraction: CtBP2 is an independent prognostic marker that promotes GLI1 induced epithelialmesenchymal transition in hepatocellular carcinoma.

Journal: Oncotarget

Published: April 24, 2026

YAP-induced BICD1 promotes hepatocellular carcinoma cell proliferation, stemness, and migration by facilitating the nuclear translocation of HIF-1α.

YAP-induced BICD1 promotes hepatocellular carcinoma cell proliferation, stemness, and migration by facilitating the nuclear translocation of HIF-1α.

Journal: Pathology, research and practice

Published: April 09, 2026

Retraction Note: Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression.

Retraction Note: Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression.

Journal: BMC cancer

Published: December 13, 2025

Comparative study of clinicopathological features and prognosis of biliary tract cancer in different locations

Comparative study of clinicopathological features and prognosis of biliary tract cancer in different locations

Journal: Zhonghua wai ke za zhi [Chinese journal of surgery]

Published: August 20, 2025

Correction: METTL3-induced lncRNA GBAP1 promotes hepatocellular carcinoma progression by activating BMP/SMAD pathway.

Correction: METTL3-induced lncRNA GBAP1 promotes hepatocellular carcinoma progression by activating BMP/SMAD pathway.

Journal: Biology direct

Published: July 09, 2025

C-Myc-activated FKBP4 promotes hepatocellular carcinoma cell proliferation and invasion by regulating the PHLPP1/AKT pathway.

C-Myc-activated FKBP4 promotes hepatocellular carcinoma cell proliferation and invasion by regulating the PHLPP1/AKT pathway.

Journal: Pathology, research and practice

Published: June 25, 2025

Retraction: Methylation-mediated repression of microRNA-129-2 suppresses cell aggressiveness by inhibiting high mobility group box 1 in human hepatocellular carcinoma.

Retraction: Methylation-mediated repression of microRNA-129-2 suppresses cell aggressiveness by inhibiting high mobility group box 1 in human hepatocellular carcinoma.

Journal: Oncotarget

Published: February 19, 2025

Retraction: Ftx non coding RNA-derived miR-545 promotes cell proliferation by targeting RIG-I in hepatocellular carcinoma.

Retraction: Ftx non coding RNA-derived miR-545 promotes cell proliferation by targeting RIG-I in hepatocellular carcinoma.

Journal: Oncotarget

Published: February 19, 2025

Identification of matrix stiffness-related molecular subtypes in HCC via integrating multi-omics analysis and machine learning algorithms.

Identification of matrix stiffness-related molecular subtypes in HCC via integrating multi-omics analysis and machine learning algorithms.

Journal: Journal of translational medicine

Published: January 03, 2025

High glucose facilitates hepatocellular carcinoma cell proliferation and invasion via WTAP-mediated HK2 mRNA stability.

High glucose facilitates hepatocellular carcinoma cell proliferation and invasion via WTAP-mediated HK2 mRNA stability.

Journal: Molecular and cellular biochemistry

Published: December 27, 2024

Development of a MVI associated HCC prognostic model through single cell transcriptomic analysis and 101 machine learning algorithms.

Development of a MVI associated HCC prognostic model through single cell transcriptomic analysis and 101 machine learning algorithms.

Journal: Scientific reports

Published: November 19, 2024

Dissecting the genetic basis and mechanisms underlying the associations between multiple extrahepatic factors and autoimmune liver diseases.

Dissecting the genetic basis and mechanisms underlying the associations between multiple extrahepatic factors and autoimmune liver diseases.

Journal: Journal of translational autoimmunity

Published: September 18, 2024

Showing 1-12 of 140

Last Updated: 09/26/2026